InMed Pharmaceuticals (INM) Gross Profit (2021 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Gross Profit of $184194.0 for Q4 2025, down 60.04% year-over-year from $460894.0 in Q4 2024, and down 54.31% quarter-over-quarter from $403159.0 in Q3 2025.
InMed Pharmaceuticals (INM) Gross Profit (2021 - 2025) Analysis & Trends
InMed Pharmaceuticals' Gross Profit history runs 5 years deep, the most recent figure standing at $184194.0 for Q4 2025.
- In Q4 2025, Gross Profit fell 60.04% year-over-year to $184194.0; the TTM figure through Dec 2025 stood at $1.3 million (down 21.65% YoY), while the FY2025 annual figure was $1.7 million, up 55.02% from the prior year.
- Gross Profit for Q4 2025 stood at $184194.0, down from $403159.0 in the prior quarter.
- The five-year high for Gross Profit was $1.6 million in Q2 2023, with the low at -$491018.0 in Q3 2022.
- The 5-year median for Gross Profit is $249714.0 (2022), against an average of $314202.0.
- Peak annual rise in Gross Profit reached 2222.82% in 2024, while the deepest fall reached 70.32% in 2024.
- InMed Pharmaceuticals' Gross Profit stood at $111555.0 in 2021, then grew by 17.58% to $131163.0 in 2022, then jumped by 147.13% to $324142.0 in 2023, then surged by 42.19% to $460894.0 in 2024, then sank by 60.04% to $184194.0 in 2025.
- Business Quant data shows INM's Gross Profit at $184194.0 in Q4 2025, $403159.0 in Q3 2025, and $576654.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | InMed Pharmaceuticals | 6.52 Mn | 1.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 184,194.00 |
| Dec 31, 2025 | 184,194.00 |
| Sep 30, 2025 | 403,159.00 |
| Sep 30, 2025 | 403,159.00 |
| Jun 30, 2025 | 576,654.00 |
| Jun 30, 2025 | 576,654.00 |
| Mar 31, 2025 | 175,625.00 |
| Mar 31, 2025 | 175,625.00 |
| Dec 31, 2024 | 460,894.00 |
| Dec 31, 2024 | 460,894.00 |
| Sep 30, 2024 | 493,413.00 |
| Sep 30, 2024 | 493,413.00 |
| Jun 30, 2024 | 466,071.00 |
| Jun 30, 2024 | 466,071.00 |
| Mar 31, 2024 | 289,458.00 |
| Mar 31, 2024 | 289,458.00 |
| Dec 31, 2023 | 324,142.00 |
| Dec 31, 2023 | 324,142.00 |
| Sep 30, 2023 | 21,242.00 |
| Sep 30, 2023 | 21,242.00 |